Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Burosumab for x-linked hypophosphataemia in adults	Burosumab (Crystiva; KRN23)	Hypophosphataemia	Endocrine Nutritional and Metabolic Disorders	2020	View \| Download
BV-NSCLC- 002 (Cimavax) for non-small-cell lung cancer wild type EGF receptor positive patients	EGF-PTI (CimaVax)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2017	View \| Download
Cabotegravir (long-acting injection) for prevention of HIV-1 infection	Cabotegravir (GSK1265744)	HIV-1 infection	Infectious Disease	2023	View \| Download
Cabotegravir (oral tablet) in combination with rilpivirine (oral tablet) for the short-term treatment of HIV-1 infection	Cabotegravir (GSK1265744) , Rilpivirine hydrochloride (Edurant)	HIV-1 infection	Infectious Disease	2019	View \| Download
Cabotegravir in combination with rilpivirine long acting injection for the treatment of HIV-1 infection	Cabotegravir (GSK1265744) , Rilpivirine hydrochloride (Edurant)	HIV-1 infection	Infectious Disease	2019	View \| Download
Cabozantinib for Hepatocellular Carcinoma	Cabozantinib (XL-184; Cabometyx; Cometriq; XL 184)	Hepatocellular carcinoma (HCC)	Gastrointestinal Cancer	2017	View \| Download
Cabozantinib for treating differentiated thyroid cancer	Cabozantinib (XL-184; Cabometyx; Cometriq; XL 184)	Differentiated thyroid cancer (DTC)	Head and Neck Cancer	2021	View \| Download
Cabozantinib in combination with atezolizumab for advanced hepatocellular carcinoma –first line	Atezolizumab (Tecentriq; MPDL3280A) , Cabozantinib (XL-184; Cabometyx; Cometriq; XL 184)	Hepatocellular carcinoma (HCC)	Gastrointestinal Cancer	2021	View \| Download
Cabozantinib with atezolizumab for treating metastatic castration-resistant prostate cancer after one novel hormonal therapy	Atezolizumab (Tecentriq; MPDL3280A) , Cabozantinib (XL-184; Cabometyx; Cometriq; XL 184)	Prostate cancer	Haematological Cancer and Lymphomas , Oncology	2023	View \| Download
Cabozantinib with nivolumab and ipilimumab for previously untreated advanced or metastatic renal cell carcinoma	Cabozantinib (XL-184; Cabometyx; Cometriq; XL 184) , Ipilimumab (Yervoy; BMS 734016; MDX 101) , Nivolumab (Opdivo; BMS-936558; ONO-4538)	Renal cell carcinoma (RCC)	Renal Cancer	2023	View \| Download